Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helena I Boshoff

Showing results (71-80 of 91) with videos related to

Pageof 10
Sort By:
Cell Chemical Biology|May 22, 2018
Construction of Fluorescent Analogs to Follow the Uptake and Distribution of Cobalamin (Vitamin B<sub>12</sub>) in Bacteria, Worms, and PlantsAndrew D Lawrence, Emi Nemoto-Smith, Evelyne Deery, et al.
Antimicrobial Agents and Chemotherapy|August 27, 2014
Respiratory flexibility in response to inhibition of cytochrome C oxidase in Mycobacterium tuberculosisKriti Arora, Bernardo Ochoa-Montaño, Patricia S Tsang, et al.
Journal of Medicinal Chemistry|January 6, 2006
Structure-activity relationships at the 5-position of thiolactomycin: an intact (5R)-isoprene unit is required for activity against the condensing enzymes from Mycobacterium tuberculosis and Escherichia coliPilho Kim, Yong-Mei Zhang, Gautham Shenoy, et al.
Structure (London, England : 1993)|January 17, 2012
Structure of Ddn, the deazaflavin-dependent nitroreductase from Mycobacterium tuberculosis involved in bioreductive activation of PA-824Susan E Cellitti, Jennifer Shaffer, David H Jones, et al.
Journal of Medicinal Chemistry|July 16, 2011
Structure-activity relationships of antitubercular nitroimidazoles. 3. Exploration of the linker and lipophilic tail of ((s)-2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazin-6-yl)-(4-trifluoromethoxybenzyl)amine (6-amino PA-824)Joseph Cherian, Inhee Choi, Amit Nayyar, et al.
Biorxiv : the Preprint Server for Biology|January 13, 2025
Fragment-based development of small molecule inhibitors targeting <i>Mycobacterium tuberculosis</i> cholesterol metabolismMadeline E Kavanagh, Kirsty J McLean, Sophie H Gilbert, et al.
ACS Infectious Diseases|June 13, 2023
MEPicides: α,β-unsaturated Fosmidomycin <i>N</i>-Acyl Analogs as Efficient Inhibitors of <i>Plasmodium falciparum</i> 1-Deoxy-d-xylulose-5-phosphate reductoisomeraseXu Wang, Rachel L Edwards, Haley S Ball, et al.
Journal of Medicinal Chemistry|September 8, 2018
MEPicides: α,β-Unsaturated Fosmidomycin Analogues as DXR Inhibitors against MalariaXu Wang, Rachel L Edwards, Haley Ball, et al.
Virulence|December 28, 2020
Tissue specific diversification, virulence and immune response to <i>Mycobacterium bovis</i> BCG in a patient with an IFN-γ R1 deficiencyCecilia B Korol, Shamira J Shallom, Kriti Arora, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|February 28, 2025
Sanfetrinem, an oral β-lactam antibiotic repurposed for the treatment of tuberculosisSantiago Ramón-García, Rubén González Del Río, María Pilar Arenaz-Callao, et al.
Pageof 10

Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
Cell Chemical Biology|May 22, 2018
Construction of Fluorescent Analogs to Follow the Uptake and Distribution of Cobalamin (Vitamin B<sub>12</sub>) in Bacteria, Worms, and PlantsAndrew D Lawrence, Emi Nemoto-Smith, Evelyne Deery, et al.
Antimicrobial Agents and Chemotherapy|August 27, 2014
Respiratory flexibility in response to inhibition of cytochrome C oxidase in Mycobacterium tuberculosisKriti Arora, Bernardo Ochoa-Montaño, Patricia S Tsang, et al.
Journal of Medicinal Chemistry|January 6, 2006
Structure-activity relationships at the 5-position of thiolactomycin: an intact (5R)-isoprene unit is required for activity against the condensing enzymes from Mycobacterium tuberculosis and Escherichia coliPilho Kim, Yong-Mei Zhang, Gautham Shenoy, et al.
Structure (London, England : 1993)|January 17, 2012
Structure of Ddn, the deazaflavin-dependent nitroreductase from Mycobacterium tuberculosis involved in bioreductive activation of PA-824Susan E Cellitti, Jennifer Shaffer, David H Jones, et al.
Journal of Medicinal Chemistry|July 16, 2011
Structure-activity relationships of antitubercular nitroimidazoles. 3. Exploration of the linker and lipophilic tail of ((s)-2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazin-6-yl)-(4-trifluoromethoxybenzyl)amine (6-amino PA-824)Joseph Cherian, Inhee Choi, Amit Nayyar, et al.
Biorxiv : the Preprint Server for Biology|January 13, 2025
Fragment-based development of small molecule inhibitors targeting <i>Mycobacterium tuberculosis</i> cholesterol metabolismMadeline E Kavanagh, Kirsty J McLean, Sophie H Gilbert, et al.
ACS Infectious Diseases|June 13, 2023
MEPicides: α,β-unsaturated Fosmidomycin <i>N</i>-Acyl Analogs as Efficient Inhibitors of <i>Plasmodium falciparum</i> 1-Deoxy-d-xylulose-5-phosphate reductoisomeraseXu Wang, Rachel L Edwards, Haley S Ball, et al.
Journal of Medicinal Chemistry|September 8, 2018
MEPicides: α,β-Unsaturated Fosmidomycin Analogues as DXR Inhibitors against MalariaXu Wang, Rachel L Edwards, Haley Ball, et al.
Virulence|December 28, 2020
Tissue specific diversification, virulence and immune response to <i>Mycobacterium bovis</i> BCG in a patient with an IFN-γ R1 deficiencyCecilia B Korol, Shamira J Shallom, Kriti Arora, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|February 28, 2025
Sanfetrinem, an oral β-lactam antibiotic repurposed for the treatment of tuberculosisSantiago Ramón-García, Rubén González Del Río, María Pilar Arenaz-Callao, et al.
Pageof 10